Y-Biologics, Inc. (KOSDAQ:338840)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,850
+970 (7.53%)
At close: Sep 12, 2025

Y-Biologics Revenue

Y-Biologics had revenue of 1.16B KRW in the quarter ending June 30, 2025, with 402.03% growth. This brings the company's revenue in the last twelve months to 5.96B, up 49.09% year-over-year. In the year 2024, Y-Biologics had annual revenue of 5.76B with 65.64% growth.

Revenue (ttm)
5.96B
Revenue Growth
+49.09%
P/S Ratio
34.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
207.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.76B2.28B65.64%
Dec 31, 20233.48B-671.48M-16.18%
Dec 31, 20224.15B-696.78M-14.37%
Dec 31, 20214.85B-1.88B-27.99%
Dec 31, 20206.73B5.38B399.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition